Intranasal Oxytocin for Frontotemporal Dementia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2024

Conditions
Frontotemporal Dementia
Interventions
DRUG

Syntocinon

Intranasal Oxytocin

Trial Locations (11)

10032

Columbia University Medical Center, New York

21224

Johns Hopkins Bayview Medical Center, Baltimore

90095

UCLA, Los Angeles

94158

University of California, San Francisco, San Francisco

98195

University of Washington, Seattle

Unknown

University of British Columbia, Vancouver

Sunnybrook Health Sciences Centre, Toronto

University Health Network, Toronto

Montreal Neurological Institute and Hospital, Montreal

N6C 0A7

Parkwood Institute, London

G1J1Z4

Laval University, Québec

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Weston Brain Institute

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Berry Consultants

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03260920 - Intranasal Oxytocin for Frontotemporal Dementia | Biotech Hunter | Biotech Hunter